U.S., Nov. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07225764) titled 'CaOx Stone Prevention' on Nov. 05.
Brief Summary: This single-center randomized controlled trial at Mount Sinai West will enroll 80 patients undergoing percutaneous nephrolithotomy for calcium oxalate stones. Participants will be randomized to receive either empiric therapy or selective therapy guided by 24-hour urine evaluation. The primary outcome is change in calcium oxalate supersaturation at 4 weeks, aiming to determine whether empiric therapy can provide outcomes comparable to selective therapy while simplifying access to prevention.
Study Start Date: Oct. 23
Study Type: INTERVENTIONAL
Condition:
Kidney Stones
Interventio...